Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis.
Panagiota AnyfantiEugenia GkaliagkousiEleni GavriilakiAreti TriantafyllouPanagiotis DolgyrasVasiliki GalanopoulouSpyros AslanidisStella DoumaPublished in: Clinical cardiology (2018)
In a relatively well-controlled cohort of RA patients with low-grade systemic inflammation and long-standing disease, serum galectin-3 might be useful as a marker of cardiac function and cardiovascular fibrosis.